All Biomarkers

    Copper-to-Zinc Ratio (Cu:Zn)

    Inflammatory
    Trace Minerals / Inflammaging
    ratio

    The copper-to-zinc ratio combines two trace minerals with opposing behavior during aging and inflammation: serum copper (an acute-phase reactant) tends to rise while zinc falls. The resulting Cu:Zn ratio is an integrative 'inflammatory-nutritional' marker that captures immunosenescence and systemic inflammatory tone better than either mineral alone.

    What It Measures

    The ratio of serum copper to serum zinc — a composite index of trace-mineral balance, antioxidant-enzyme capacity and low-grade inflammation that rises with age and inflammatory burden.

    Optimal vs. Lab Range

    Longevity Optimal
    ~<=1.0 (favorable; lab- and assay-dependent)

    Target range for optimal health and longevity based on research.

    Standard Lab
    No universal clinical reference range; typical healthy adult serum copper ~70-140 ug/dL and zinc ~70-120 ug/dL give a ratio near ~0.7-1.0. Higher ratios (>=~1.2) mark inflammatory-nutritional imbalance.

    Population-based reference range from standard labs.

    Why It Matters

    A rising copper-to-zinc ratio reflects the combined effect of inflammation-driven copper elevation and zinc depletion, both features of 'inflammaging' and immunosenescence. Prospective cohorts in older adults consistently link a higher Cu:Zn ratio with greater all-cause mortality, frailty, sarcopenia and cardiovascular risk — higher-ratio groups have shown roughly 1.3-1.9-fold higher mortality risk, and a 2025 longitudinal aging study found a high ratio predicted incident sarcopenia and adverse 5-year outcomes. Because it integrates nutritional status and inflammatory tone, the Cu:Zn ratio is a low-cost adjunct for biological-aging assessment, best interpreted alongside hs-CRP and other inflammatory markers and away from acute illness.

    When Low

    A lower Cu:Zn ratio (around or below ~1.0) generally reflects favorable trace-mineral balance and low inflammatory burden.

    When Optimal

    A ratio near or below ~1.0 is generally considered favorable; interpret together with hs-CRP and nutritional status.

    When High

    A higher ratio (roughly >=1.2-1.5) is associated with inflammation, zinc insufficiency and increased mortality, frailty and cardiovascular risk; evaluate inflammatory drivers and zinc status.

    How to Optimize

    Interpretation and management are individualized: a high ratio usually reflects underlying inflammation and/or relative zinc insufficiency rather than copper excess, so the priority is identifying and addressing inflammatory drivers (excess adiposity, infection, chronic disease) and ensuring adequate dietary zinc. Zinc supplementation can lower the ratio but must be balanced against copper status to avoid inducing copper deficiency, so it is done under physician guidance. Retest away from acute illness. This content is educational and not a substitute for medical advice.

    Key Interventions & Linked Compounds

    Moderate evidence

    Key Interventions

    Treat inflammatory drivers
    optimize dietary zinc
    physician-guided zinc repletion (with copper monitoring)

    Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.

    Ordering Notes

    Specimen

    Calculated from serum copper and serum zinc (both measured by ICP-MS or atomic absorption)

    Patient prep

    No fasting required. Maintain usual diet and medications unless advised.

    Recommended cadence

    Annual, or as advised; interpret away from acute illness

    Reporting unit

    ratio

    Pre-analytic notes

    Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.

    Recommended Follow-Up Actions

    1. 1

      Confirm the result is reliable

      Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift Copper-to-Zinc Ratio (Cu:Zn).

    2. 2

      Compare against optimal, not just lab range

      Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.

    3. 3

      Pair with related markers

      Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.

    4. 4

      Discuss interventions with a clinician

      Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.

    5. 5

      Re-test on a defined cadence

      If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.

    Testing Information

    Recommended Frequency

    Annual, or as advised; interpret away from acute illness

    Fasting Requirement

    No fasting required

    Available Test Types

    Calculated from serum copper and serum zinc (both measured by ICP-MS or atomic absorption)
    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation